
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>ar05</td><td>1</td><td>Bisoprolol</td><td>Ramipril</td><td>Ramipril may increase the hypotensive activities of Bisoprolol.</td></tr><tr><td>ar05</td><td>1</td><td>Canrenone</td><td>Bisoprolol</td><td>The risk or severity of hyperkalemia can be increased when Bisoprolol is
combined with Canrenone.</td></tr><tr><td>ar05</td><td>1</td><td>Canrenone</td><td>Ramipril</td><td>The risk or severity of hyperkalemia can be increased when Canrenone is combined
with Ramipril.</td></tr><tr><td>ar05</td><td>1</td><td>Dapagliflozin</td><td>Bisoprolol</td><td>The therapeutic efficacy of Dapagliflozin can be increased when used in
combination with Bisoprolol.</td></tr><tr><td>ar05</td><td>1</td><td>Dapagliflozin</td><td>Ramipril</td><td>The risk or severity of renal failure, hypotension, and hyperkalemia can be
increased when Dapagliflozin is combined with Ramipril.</td></tr><tr><td>ar05</td><td>1</td><td>Tenofovir alafenamide</td><td>Atorvastatin</td><td>The excretion of Tenofovir alafenamide can be decreased when combined with
Atorvastatin.</td></tr><tr><td>ar05</td><td>1</td><td>Tenofovir alafenamide</td><td>Bisoprolol</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Bisoprolol.</td></tr></tbody></table></div>
